D. E. Shaw & Co., Inc. Halozyme Therapeutics, Inc. Put Options Transaction History

D. E. Shaw & Co., Inc.

2 transactions

Quarter	Operation	Price Per put	puts change	puts Held	SEC Form
Q1 2018 May 15, 2018	SELL	$17.06 - $21.2 $1.28 Million - $1.59 Million	-75,000 Reduced 83.33%	15,000 $294,000
Q4 2017 Feb 14, 2018	BUY	$16.75 - $20.8 $1.51 Million - $1.87 Million	90,000	90,000 $1.82 Million

544

125M

294K

180K

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.65B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.